Semaglutide Overview

Semaglutide is a synthetic research peptide structurally designed to mimic glucagon-like peptide-1 (GLP-1) analogs. It is of interest in studies related to peptide receptor interactions and incretin pathways. Semaglutide is commonly used in preclinical research models investigating metabolic signaling and peptide pharmacokinetics.

Product Details

• Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLRGRG
• Molecular Formula: C187H291N45O59
• Molecular Weight: 4113.64 g/mol
• PubChem CID: 56843331
• CAS Number: 910463-68-2

Research Highlights

1. GLP-1 Receptor Interaction: Semaglutide is widely utilized in research focused on GLP-1 receptor activity and peptide-based modulation of cellular signaling pathways.
2. Peptide Stability: Studies often investigate its prolonged half-life and resistance to enzymatic degradation compared to natural GLP-1 analogs.
3. Pharmacokinetic Profiles: Semaglutide is used to examine controlled-release properties and bioavailability through various peptide delivery systems in experimental settings.
4. Metabolic Pathway Modeling: This peptide aids researchers in modeling glucose-related signaling mechanisms in vitro and in vivo animal studies.

Usage and Safety Information

This compound is intended for laboratory research use only. It is not approved for human consumption, medical, or veterinary use. Proper lab safety protocols and storage conditions should be followed when handling this product.